0001225208-24-003201.txt : 20240228
0001225208-24-003201.hdr.sgml : 20240228
20240228165957
ACCESSION NUMBER: 0001225208-24-003201
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240227
FILED AS OF DATE: 20240228
DATE AS OF CHANGE: 20240228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BOURLA ALBERT
CENTRAL INDEX KEY: 0001595703
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-03619
FILM NUMBER: 24696521
MAIL ADDRESS:
STREET 1: PFIZER INC. ATTN CORP. SECRETARY
STREET 2: 235 EAST 42ND STREET
CITY: NEW YORK
STATE: NY
ZIP: 10017
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PFIZER INC
CENTRAL INDEX KEY: 0000078003
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 135315170
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 66 HUDSON BOULEVARD EAST
CITY: NEW YORK
STATE: NY
ZIP: 10001-2192
BUSINESS PHONE: 2127332323
MAIL ADDRESS:
STREET 1: 66 HUDSON BOULEVARD EAST
CITY: NEW YORK
STATE: NY
ZIP: 10001-2192
FORMER COMPANY:
FORMER CONFORMED NAME: PFIZER CHARLES & CO INC
DATE OF NAME CHANGE: 19710908
4
1
doc4.xml
X0508
4
2024-02-27
0000078003
PFIZER INC
PFE
0001595703
BOURLA ALBERT
66 HUDSON BOULEVARD EAST
ATTN: CORPORATE SECRETARY
NEW YORK
NY
10001-2192
1
1
Chairman & CEO
0
Stock Appreciation Rights
26.8900
2024-02-27
4
A
0
644640.0000
0.0000
A
2029-02-27
2029-02-27
Common Stock
644640.0000
644640.0000
D
Stock Appreciation Rights
26.8900
2024-02-27
4
A
0
569600.0000
0.0000
A
2031-02-27
2031-02-27
Common Stock
569600.0000
569600.0000
D
The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.
Susan E. Grant, by power of atty., for Albert Bourla
2024-02-28